no code implementations • 8 Apr 2022 • Subhrajit Roy, Diana Mincu, Lev Proleev, Negar Rostamzadeh, Chintan Ghate, Natalie Harris, Christina Chen, Jessica Schrouff, Nenad Tomasev, Fletcher Lee Hartsell, Katherine Heller
To the best of our knowledge, our results are the first to show that it is possible to predict disease progression using POMs and demographic data in the context of both clinical trials and smartphone-base studies by using two datasets.